|
ZNF367 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.60309609610022E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.51316761740372E-12 |
| Normal-vs-Stage2 |
1.414930E-04 |
| Normal-vs-Stage3 |
1.8113999999958E-06 |
| Normal-vs-Stage4 |
1.022320E-02 |
| Stage1-vs-Stage2 |
4.931400E-01 |
| Stage1-vs-Stage3 |
2.259400E-01 |
| Stage1-vs-Stage4 |
1.500360E-02 |
| Stage2-vs-Stage3 |
8.360000E-01 |
| Stage2-vs-Stage4 |
2.035600E-01 |
| Stage3-vs-Stage4 |
2.238200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.63409977058404E-10 |
| Normal-vs-AfricanAmerican |
2.144500E-03 |
| Normal-vs-Asian |
1.61170999999349E-05 |
| Caucasian-vs-AfricanAmerican |
2.125200E-01 |
| Caucasian-vs-Asian |
3.365400E-01 |
| AfricanAmerican-vs-Asian |
6.568400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.12190000001178E-06 |
| Normal-vs-Female |
8.37019342725398E-12 |
| Male-vs-Female |
2.695000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.02310382388282E-11 |
| Normal-vs-Age(41-60Yrs) |
1.74750000025981E-07 |
| Normal-vs-Age(61-80Yrs) |
4.44569999999977E-05 |
| Normal-vs-Age(81-100Yrs) |
2.804400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.103100E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.566840E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.623400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.479000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.609000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.433000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.412000E-01 |
| Classical-VS-Follicular |
4.541200E-01 |
| Classical-VS-Other |
8.959000E-01 |
| Classical-VS-Normal |
2.06610284436692E-11 |
| Tall-VS-Follicular |
1.509190E-01 |
| Tall-VS-Other |
8.673400E-01 |
| Tall-VS-Normal |
4.01850000000259E-05 |
| Follicular-VS-Other |
7.456000E-01 |
| Follicular-VS-Normal |
1.58969999997094E-06 |
| Other-VS-Normal |
2.619200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.04140038206901E-10 |
| Normal-vs-N1 |
2.193600E-04 |
| N0-vs-N1 |
3.062400E-01 |
|
|
